Primary Aldosteronism Evidence Reshapes Care Pathways
from TheBrief.Health Hosted by TheBrief.Health
Updated evidence reinforces primary aldosteronism as a treatable cause of hypertension, supporting targeted evaluation, subtype classification, and aldosterone-directed therapy beyond routine blood pressure management.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of TheBrief.Health?
This episode is 1 minute long.
When was this TheBrief.Health episode published?
This episode was published on September 10, 2026.
Can I download this TheBrief.Health episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.